Viewing Study NCT00772668

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2026-01-02 @ 11:47 AM
Study NCT ID: NCT00772668
Status: TERMINATED
Last Update Posted: 2017-12-11
First Post: 2008-10-12
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL
Sponsor: University of Miami
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
None Follicular Lymphoma View
None Marginal Zone Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage III grade 1 follicular lymphoma View
None stage IV grade 1 follicular lymphoma View
None stage III grade 2 follicular lymphoma View
None stage IV grade 2 follicular lymphoma View
None stage III marginal zone lymphoma View
None stage IV marginal zone lymphoma View